Minapharm Pharmaceuticals

Minapharm Pharmaceuticals stands as a leading pharmaceutical company in Egypt and the Middle East, recognized as the premier biopharmaceutical entity in Africa. With over two decades of expertise in cellular and bioprocess engineering, Minapharm Pharmaceuticals, headquartered in Cairo, excels in commercializing a diverse portfolio of over 100 life-saving and life-enhancing products, encompassing everything from small molecules to complex genetically-engineered proteins, alongside a noteworthy immunotherapy pipeline.

Together with its wholly-owned subsidiary, ProBioGen, based in Berlin, Minapharm Pharmaceuticals has cultivated an integrated business model, positioning itself as the region's sole gene-to-market biopharmaceutical company. Minapharm Pharmaceuticals operates from its primary location at El Bardissi Street 2T Takseem Asmaa Fahmy, Ard El Golf, Heliopolis Cairo, EG, and also maintains a presence at Mina Street, 3rd Industrial Zone A2, 10th of Ramadan City Sharkia, EG. These strategic locations support Minapharm Pharmaceuticals' commitment to delivering high-quality pharmaceutical solutions.

We invite the management of Minapharm Pharmaceuticals to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, further solidifying Minapharm Pharmaceuticals' presence in the pharmaceutical landscape.